Amedisys Historical Cash Flow
| AMED Stock | USD 92.74 0.36 0.39% |
Analysis of Amedisys cash flow over time is an excellent tool to project Amedisys future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 225.9 M or Change In Working Capital of 41.9 M as it is a great indicator of Amedisys ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Amedisys latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Amedisys is a good buy for the upcoming year.
Amedisys |
About Amedisys Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Amedisys balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Amedisys's non-liquid assets can be easily converted into cash.
Amedisys Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Amedisys to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Amedisys operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Amedisys' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Amedisys current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amedisys. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.At present, Amedisys' Free Cash Flow is projected to increase significantly based on the last few years of reporting. The current year's Change In Working Capital is expected to grow to about 41.9 M, whereas Other Cashflows From Financing Activities is forecasted to decline to (44.9 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Begin Period Cash Flow | 45.8M | 54.1M | 138.9M | 145.8M | End Period Cash Flow | 54.1M | 138.9M | 303.2M | 318.4M |
Amedisys cash flow statement Correlations
Click cells to compare fundamentals
Amedisys Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Amedisys cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (13.1M) | (37.6M) | 8.4M | 84.7M | 164.4M | 172.6M | |
| Free Cash Flow | 283.6M | 182.2M | 126.1M | 124.5M | 215.1M | 225.9M | |
| Change In Working Capital | 26.2M | (131.0M) | (105.0M) | (63.2M) | 39.9M | 41.9M | |
| Other Cashflows From Financing Activities | 742.7M | 723.6M | (5.1M) | (5.0M) | (42.8M) | (44.9M) | |
| Depreciation | 67.9M | 71.3M | 71.0M | 57.8M | 60.5M | 63.5M | |
| Other Non Cash Items | 9.4M | (29.9M) | 9.7M | 102.6M | 45.1M | 47.3M | |
| Capital Expenditures | 5.3M | 6.7M | 7.2M | 12.7M | 6.6M | 6.2M | |
| Change To Account Receivables | 2.1M | (18.0M) | (14.2M) | (26.7M) | 16.5M | 17.3M | |
| Net Income | 185.2M | 210.2M | 117.7M | (9.7M) | 38.2M | 27.4M | |
| Total Cash From Financing Activities | (15.0M) | 55.1M | (30.4M) | (87.5M) | (48.9M) | (46.5M) | |
| End Period Cash Flow | 83.4M | 45.8M | 54.1M | 138.9M | 303.2M | 318.4M | |
| Begin Period Cash Flow | 96.5M | 83.4M | 45.8M | 54.1M | 138.9M | 145.8M | |
| Total Cash From Operating Activities | 289.0M | 188.9M | 133.3M | 137.2M | 221.7M | 232.7M | |
| Stock Based Compensation | 26.7M | 23.8M | 16.6M | 29.0M | 30.6M | 29.1M | |
| Sale Purchase Of Stock | (54.5M) | (116.8M) | (25.3M) | (6.5M) | (6.2M) | (6.5M) | |
| Total Cashflows From Investing Activities | (352.9M) | (287.1M) | (281.6M) | (94.5M) | (85.0M) | (89.3M) | |
| Other Cashflows From Investing Activities | (298.8M) | 135K | 318K | (6.9M) | (1.8M) | (1.9M) | |
| Change To Liabilities | 30.4M | 69.5M | (4.4M) | (43.3M) | (39.0M) | (37.0M) | |
| Change Receivables | (24.1M) | 2.1M | (18.0M) | (14.2M) | (12.8M) | (13.4M) | |
| Net Borrowings | 56.0M | (29.2M) | 230.2M | (13.3M) | (15.3M) | (16.1M) | |
| Dividends Paid | 3.6B | 4.0B | 1.6M | 6.5M | 7.5M | 7.1M | |
| Cash And Cash Equivalents Changes | 76.3M | (13.1M) | (37.6M) | 8.4M | 7.5M | 7.9M | |
| Cash Flows Other Operating | (1.7M) | (3.3M) | (12.6M) | (1.5M) | (1.3M) | (1.3M) | |
| Change To Netincome | 50.2M | 5.8M | 38.7M | 48.7M | 43.8M | 72.1M | |
| Investments | 17.0M | (5.2M) | (15.6M) | 35.2M | (8.4M) | (7.9M) | |
| Change To Operating Activities | 4.1M | 22.2M | (108.6M) | (95.7M) | (86.1M) | (81.8M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amedisys. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.35) | Earnings Share 1.31 | Revenue Per Share | Quarterly Revenue Growth 0.048 | Return On Assets |
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.